Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.
Identifieur interne : 004C44 ( PubMed/Corpus ); précédent : 004C43; suivant : 004C45Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.
Auteurs : A. Fève ; B. Angelard ; G. Fénelon ; M. Logak ; A. Guillard ; J. Lacau Saint-GuilySource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1993.
English descriptors
- KwdEn :
- Airway Obstruction (chemically induced), Airway Obstruction (drug therapy), Botulinum Toxins (administration & dosage), Dyskinesia, Drug-Induced (drug therapy), Electromyography (drug effects), Flupenthixol (administration & dosage), Flupenthixol (adverse effects), Humans, Injections, Intramuscular, Laryngeal Diseases (chemically induced), Laryngeal Diseases (drug therapy), Laryngeal Muscles (drug effects), Male, Middle Aged, Neurologic Examination (drug effects), Spouse Abuse (prevention & control), Violence.
- MESH :
- chemical , administration & dosage : Botulinum Toxins, Flupenthixol.
- chemical , adverse effects : Flupenthixol.
- chemically induced : Airway Obstruction, Laryngeal Diseases.
- drug effects : Electromyography, Laryngeal Muscles, Neurologic Examination.
- drug therapy : Airway Obstruction, Dyskinesia, Drug-Induced, Laryngeal Diseases.
- prevention & control : Spouse Abuse.
- Humans, Injections, Intramuscular, Male, Middle Aged, Violence.
Abstract
We report a case of laryngeal dyskinesia resulting in severe rest and exercise dyspnea. A 51-year-old man treated for 2 years with flupentixol, an incisive neuroleptic, developed severe dyspnea due to intermittent, rhythmic, and dystonic movements of the vocal cords and upper airway. Local injections of botulinum toxin resulted in spectacular regression of laryngeal spasms and major improvement in breathing. This case emphasizes the risk of upper respiratory dyskinesias associated with neuroleptic treatment and shows the feasibility of a new local treatment in this life-threatening disorder.
DOI: 10.1002/mds.870080220
PubMed: 8474494
Links to Exploration step
pubmed:8474494Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.</title><author><name sortKey="Feve, A" sort="Feve, A" uniqKey="Feve A" first="A" last="Fève">A. Fève</name><affiliation><nlm:affiliation>Service de neurologie, Hôpital Tenon, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Angelard, B" sort="Angelard, B" uniqKey="Angelard B" first="B" last="Angelard">B. Angelard</name></author><author><name sortKey="Fenelon, G" sort="Fenelon, G" uniqKey="Fenelon G" first="G" last="Fénelon">G. Fénelon</name></author><author><name sortKey="Logak, M" sort="Logak, M" uniqKey="Logak M" first="M" last="Logak">M. Logak</name></author><author><name sortKey="Guillard, A" sort="Guillard, A" uniqKey="Guillard A" first="A" last="Guillard">A. Guillard</name></author><author><name sortKey="Lacau Saint Guily, J" sort="Lacau Saint Guily, J" uniqKey="Lacau Saint Guily J" first="J" last="Lacau Saint-Guily">J. Lacau Saint-Guily</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1993">1993</date><idno type="RBID">pubmed:8474494</idno><idno type="pmid">8474494</idno><idno type="doi">10.1002/mds.870080220</idno><idno type="wicri:Area/PubMed/Corpus">004C44</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.</title><author><name sortKey="Feve, A" sort="Feve, A" uniqKey="Feve A" first="A" last="Fève">A. Fève</name><affiliation><nlm:affiliation>Service de neurologie, Hôpital Tenon, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Angelard, B" sort="Angelard, B" uniqKey="Angelard B" first="B" last="Angelard">B. Angelard</name></author><author><name sortKey="Fenelon, G" sort="Fenelon, G" uniqKey="Fenelon G" first="G" last="Fénelon">G. Fénelon</name></author><author><name sortKey="Logak, M" sort="Logak, M" uniqKey="Logak M" first="M" last="Logak">M. Logak</name></author><author><name sortKey="Guillard, A" sort="Guillard, A" uniqKey="Guillard A" first="A" last="Guillard">A. Guillard</name></author><author><name sortKey="Lacau Saint Guily, J" sort="Lacau Saint Guily, J" uniqKey="Lacau Saint Guily J" first="J" last="Lacau Saint-Guily">J. Lacau Saint-Guily</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="1993" type="published">1993</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Airway Obstruction (chemically induced)</term><term>Airway Obstruction (drug therapy)</term><term>Botulinum Toxins (administration & dosage)</term><term>Dyskinesia, Drug-Induced (drug therapy)</term><term>Electromyography (drug effects)</term><term>Flupenthixol (administration & dosage)</term><term>Flupenthixol (adverse effects)</term><term>Humans</term><term>Injections, Intramuscular</term><term>Laryngeal Diseases (chemically induced)</term><term>Laryngeal Diseases (drug therapy)</term><term>Laryngeal Muscles (drug effects)</term><term>Male</term><term>Middle Aged</term><term>Neurologic Examination (drug effects)</term><term>Spouse Abuse (prevention & control)</term><term>Violence</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins</term><term>Flupenthixol</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Flupenthixol</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Airway Obstruction</term><term>Laryngeal Diseases</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Electromyography</term><term>Laryngeal Muscles</term><term>Neurologic Examination</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Airway Obstruction</term><term>Dyskinesia, Drug-Induced</term><term>Laryngeal Diseases</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Spouse Abuse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Injections, Intramuscular</term><term>Male</term><term>Middle Aged</term><term>Violence</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We report a case of laryngeal dyskinesia resulting in severe rest and exercise dyspnea. A 51-year-old man treated for 2 years with flupentixol, an incisive neuroleptic, developed severe dyspnea due to intermittent, rhythmic, and dystonic movements of the vocal cords and upper airway. Local injections of botulinum toxin resulted in spectacular regression of laryngeal spasms and major improvement in breathing. This case emphasizes the risk of upper respiratory dyskinesias associated with neuroleptic treatment and shows the feasibility of a new local treatment in this life-threatening disorder.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">8474494</PMID><DateCreated><Year>1993</Year><Month>05</Month><Day>18</Day></DateCreated><DateCompleted><Year>1993</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>2</Issue><PubDate><Year>1993</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.</ArticleTitle><Pagination><MedlinePgn>217-9</MedlinePgn></Pagination><Abstract><AbstractText>We report a case of laryngeal dyskinesia resulting in severe rest and exercise dyspnea. A 51-year-old man treated for 2 years with flupentixol, an incisive neuroleptic, developed severe dyspnea due to intermittent, rhythmic, and dystonic movements of the vocal cords and upper airway. Local injections of botulinum toxin resulted in spectacular regression of laryngeal spasms and major improvement in breathing. This case emphasizes the risk of upper respiratory dyskinesias associated with neuroleptic treatment and shows the feasibility of a new local treatment in this life-threatening disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fève</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de neurologie, Hôpital Tenon, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelard</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Fénelon</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Logak</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Guillard</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lacau Saint-Guily</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>UNITED STATES</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber><NameOfSubstance UI="D001905">Botulinum Toxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>FA0UYH6QUO</RegistryNumber><NameOfSubstance UI="D005475">Flupenthixol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000402">Airway Obstruction</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName><QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001905">Botulinum Toxins</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D004409">Dyskinesia, Drug-Induced</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D004576">Electromyography</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005475">Flupenthixol</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007273">Injections, Intramuscular</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007818">Laryngeal Diseases</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName><QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007821">Laryngeal Muscles</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013179">Spouse Abuse</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000517">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D014754">Violence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8474494</ArticleId><ArticleId IdType="doi">10.1002/mds.870080220</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C44 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004C44 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:8474494
|texte= Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:8474494" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |